user

Commentary: efficacy and safety of ribavirin plus pegylated interferon-alpha in geriatric patients with chronic hepatitis C - authors' reply

被引：0
|
作者：
Hu, C-C. [1 ,2 ]
Chien, R-N. [1 ,2 ]
机构：
[1] Chang Gung Mem Hosp, Liver Res Unit, Keelung, Taiwan
[2] Univ Coll Med, Keelung, Taiwan
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2013年 / 37卷 / 04期
关键词：
BOCEPREVIR;
D O I：
10.1111/apt.12189
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：492 / 492
页数：1
相关论文
共 50 条
  • [1] Commentary: efficacy and safety of ribavirin plus pegylated interferon-alpha in geriatric patients with chronic hepatitis C
    Hadziyannis, S. J.
    Sevastianos, V.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (04) : 491 - 491
  • [2] Efficacy and safety of ribavirin plus pegylated interferon alfa in geriatric patients with chronic hepatitis C
    Hu, C. -C.
    Lin, C. -L.
    Kuo, Y. -L.
    Chien, C. -H.
    Chen, S. -W.
    Yen, C. -L.
    Lin, C. -Y.
    Chien, R. -N.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (01) : 81 - 90
  • [3] EFFICACY AND SAFETY OF PEGYLATED INTERFERON-ALPHA PLUS RIBAVIRIN COMBINATION THERAPY IN OLD AGE CHRONIC HEPATITIS C PATIENTS
    Dai, C. -Y.
    Huang, C. -F.
    Yu, M. -L
    Huang, J-F
    Chuang, W-L.
    [J]. JOURNAL OF HEPATOLOGY, 2009, 50 : S227 - S227
  • [4] Assessment of efficacy and safety of PEGylated interferon plus ribavirin in elderly patients with chronic hepatitis C
    Wen, Shi-Chi
    Cheng, Lung-Chih
    Hsu, Jui-Hung
    Lai, Hsin-Wen
    Shih, Pei-Chen
    Tsai, Chi-Chang
    Lee, Ching-Chang
    Kuo, Wu-Hsien
    [J]. ADVANCES IN DIGESTIVE MEDICINE, 2018, 5 (03) : 84 - 92
  • [5] Serum procalcitonin levels in chronic hepatitis C patients under pegylated interferon-alpha plus ribavirin treatment
    Elefsiniotis, Ioannis S.
    Petrocheilou, Aikaterini
    Scarmeas, Nikolaos
    Ketikoglou, Ioannis
    Pantazis, Konstantinos D.
    Toutouza, Marina
    Tsianos, Epameinondas V.
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2006, 37 (04) : 329 - 331
  • [6] PEGYLATED INTERFERON ALPHA PLUS RIBAVIRIN TREATMENT OF CHRONIC HEPATITIS C IN PSORIATIC PATIENTS
    Tomasiewicz, Krzysztof
    Modrzewska, Romana
    [J]. HEPATOLOGY, 2008, 48 (04) : 907A - 907A
  • [7] Serious psychiatric adverse events in chronic Hepatitis C patients treated with Pegylated or recombinant Interferon-Alpha plus Ribavirin
    Drozdz, W.
    Borkowska, A.
    Kozielewz, D.
    Dybowska, D.
    Ziolkowska-Kochan, M.
    Halota, W.
    [J]. EUROPEAN PSYCHIATRY, 2008, 23 : S366 - S367
  • [8] Pegylated interferon plus ribavirin in chronic hepatitis c
    Bruce R. Bacon
    [J]. Current Gastroenterology Reports, 2001, 3 (1) : 84 - 84
  • [9] Efficacy and tolerability of pegylated interferon alpha-2a plus ribavirin versus pegylated interferon alpha-2b plus ribavirin, in treatment naive chronic hepatitis C patients
    Lee, S. Y.
    Lee, S.
    Ko, K. S.
    Kim, I. H.
    Kim, S. H.
    Kim, S. W.
    Lee, S. O.
    Lee, S. T.
    Kim, D. G.
    Choi, C. S.
    Cho, E. Y.
    Kim, H. C.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A176 - A176
  • [10] Ischemic colitis during pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C
    Leung, Yvette
    Urbanski, Stefan J.
    Schindel, Lynn
    Myers, Robert P.
    [J]. CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 20 (10) : 661 - 663
12345